Protocol for the Stimulating β3-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease

Guardado en:
Detalles Bibliográficos
Autores principales: Clara Chow, Anthony C Keech, Laurent Billot, Sanjay Patel, Kristen J Bubb, Stuart M Grieve, Gemma A Figtree, Jonathan Golledge, Jason A Harmer, Meghan Finemore, Sarah Joy Aitken, Zara S Ali, Rebecca Mister, Michael P Gray, Naomi Hamburg, Vikram Puttaswamy
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2021
Materias:
R
Acceso en línea:https://doaj.org/article/abf69ce417d94e56a77017f32616adc9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:abf69ce417d94e56a77017f32616adc9
record_format dspace
spelling oai:doaj.org-article:abf69ce417d94e56a77017f32616adc92021-11-19T01:00:06ZProtocol for the Stimulating β3-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease10.1136/bmjopen-2021-0498582044-6055https://doaj.org/article/abf69ce417d94e56a77017f32616adc92021-09-01T00:00:00Zhttps://bmjopen.bmj.com/content/11/9/e049858.fullhttps://doaj.org/toc/2044-6055Clara ChowAnthony C KeechLaurent BillotSanjay PatelKristen J BubbStuart M GrieveGemma A FigtreeJonathan GolledgeJason A HarmerMeghan FinemoreSarah Joy AitkenZara S AliRebecca MisterMichael P GrayNaomi HamburgVikram PuttaswamyBMJ Publishing GrouparticleMedicineRENBMJ Open, Vol 11, Iss 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
Clara Chow
Anthony C Keech
Laurent Billot
Sanjay Patel
Kristen J Bubb
Stuart M Grieve
Gemma A Figtree
Jonathan Golledge
Jason A Harmer
Meghan Finemore
Sarah Joy Aitken
Zara S Ali
Rebecca Mister
Michael P Gray
Naomi Hamburg
Vikram Puttaswamy
Protocol for the Stimulating β3-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease
format article
author Clara Chow
Anthony C Keech
Laurent Billot
Sanjay Patel
Kristen J Bubb
Stuart M Grieve
Gemma A Figtree
Jonathan Golledge
Jason A Harmer
Meghan Finemore
Sarah Joy Aitken
Zara S Ali
Rebecca Mister
Michael P Gray
Naomi Hamburg
Vikram Puttaswamy
author_facet Clara Chow
Anthony C Keech
Laurent Billot
Sanjay Patel
Kristen J Bubb
Stuart M Grieve
Gemma A Figtree
Jonathan Golledge
Jason A Harmer
Meghan Finemore
Sarah Joy Aitken
Zara S Ali
Rebecca Mister
Michael P Gray
Naomi Hamburg
Vikram Puttaswamy
author_sort Clara Chow
title Protocol for the Stimulating β3-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease
title_short Protocol for the Stimulating β3-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease
title_full Protocol for the Stimulating β3-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease
title_fullStr Protocol for the Stimulating β3-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease
title_full_unstemmed Protocol for the Stimulating β3-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease
title_sort protocol for the stimulating β3-adrenergic receptors for peripheral artery disease (star-pad) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease
publisher BMJ Publishing Group
publishDate 2021
url https://doaj.org/article/abf69ce417d94e56a77017f32616adc9
work_keys_str_mv AT clarachow protocolforthestimulatingb3adrenergicreceptorsforperipheralarterydiseasestarpadtrialadoubleblindedrandomisedplacebocontrolledstudyevaluatingtheeffectsofmirabegrononfunctionalperformanceinpatientswithperipheralarterialdisease
AT anthonyckeech protocolforthestimulatingb3adrenergicreceptorsforperipheralarterydiseasestarpadtrialadoubleblindedrandomisedplacebocontrolledstudyevaluatingtheeffectsofmirabegrononfunctionalperformanceinpatientswithperipheralarterialdisease
AT laurentbillot protocolforthestimulatingb3adrenergicreceptorsforperipheralarterydiseasestarpadtrialadoubleblindedrandomisedplacebocontrolledstudyevaluatingtheeffectsofmirabegrononfunctionalperformanceinpatientswithperipheralarterialdisease
AT sanjaypatel protocolforthestimulatingb3adrenergicreceptorsforperipheralarterydiseasestarpadtrialadoubleblindedrandomisedplacebocontrolledstudyevaluatingtheeffectsofmirabegrononfunctionalperformanceinpatientswithperipheralarterialdisease
AT kristenjbubb protocolforthestimulatingb3adrenergicreceptorsforperipheralarterydiseasestarpadtrialadoubleblindedrandomisedplacebocontrolledstudyevaluatingtheeffectsofmirabegrononfunctionalperformanceinpatientswithperipheralarterialdisease
AT stuartmgrieve protocolforthestimulatingb3adrenergicreceptorsforperipheralarterydiseasestarpadtrialadoubleblindedrandomisedplacebocontrolledstudyevaluatingtheeffectsofmirabegrononfunctionalperformanceinpatientswithperipheralarterialdisease
AT gemmaafigtree protocolforthestimulatingb3adrenergicreceptorsforperipheralarterydiseasestarpadtrialadoubleblindedrandomisedplacebocontrolledstudyevaluatingtheeffectsofmirabegrononfunctionalperformanceinpatientswithperipheralarterialdisease
AT jonathangolledge protocolforthestimulatingb3adrenergicreceptorsforperipheralarterydiseasestarpadtrialadoubleblindedrandomisedplacebocontrolledstudyevaluatingtheeffectsofmirabegrononfunctionalperformanceinpatientswithperipheralarterialdisease
AT jasonaharmer protocolforthestimulatingb3adrenergicreceptorsforperipheralarterydiseasestarpadtrialadoubleblindedrandomisedplacebocontrolledstudyevaluatingtheeffectsofmirabegrononfunctionalperformanceinpatientswithperipheralarterialdisease
AT meghanfinemore protocolforthestimulatingb3adrenergicreceptorsforperipheralarterydiseasestarpadtrialadoubleblindedrandomisedplacebocontrolledstudyevaluatingtheeffectsofmirabegrononfunctionalperformanceinpatientswithperipheralarterialdisease
AT sarahjoyaitken protocolforthestimulatingb3adrenergicreceptorsforperipheralarterydiseasestarpadtrialadoubleblindedrandomisedplacebocontrolledstudyevaluatingtheeffectsofmirabegrononfunctionalperformanceinpatientswithperipheralarterialdisease
AT zarasali protocolforthestimulatingb3adrenergicreceptorsforperipheralarterydiseasestarpadtrialadoubleblindedrandomisedplacebocontrolledstudyevaluatingtheeffectsofmirabegrononfunctionalperformanceinpatientswithperipheralarterialdisease
AT rebeccamister protocolforthestimulatingb3adrenergicreceptorsforperipheralarterydiseasestarpadtrialadoubleblindedrandomisedplacebocontrolledstudyevaluatingtheeffectsofmirabegrononfunctionalperformanceinpatientswithperipheralarterialdisease
AT michaelpgray protocolforthestimulatingb3adrenergicreceptorsforperipheralarterydiseasestarpadtrialadoubleblindedrandomisedplacebocontrolledstudyevaluatingtheeffectsofmirabegrononfunctionalperformanceinpatientswithperipheralarterialdisease
AT naomihamburg protocolforthestimulatingb3adrenergicreceptorsforperipheralarterydiseasestarpadtrialadoubleblindedrandomisedplacebocontrolledstudyevaluatingtheeffectsofmirabegrononfunctionalperformanceinpatientswithperipheralarterialdisease
AT vikramputtaswamy protocolforthestimulatingb3adrenergicreceptorsforperipheralarterydiseasestarpadtrialadoubleblindedrandomisedplacebocontrolledstudyevaluatingtheeffectsofmirabegrononfunctionalperformanceinpatientswithperipheralarterialdisease
_version_ 1718420627913703424